Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.
Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, Miyairi Y, Murai K, Shimosegawa K, Yoshida K, Inokura K, Fukuhara N, Harigae H, Sato R, Ishizawa K, Tajima K, Saitou S, Fukatsu M, Ikezoe T, Tsunoda S, Mita M, Mori J, Kowata S, Ito S.
Oyake T, et al. Among authors: tamai y.
J Clin Exp Hematop. 2024 Sep 28;64(3):191-202. doi: 10.3960/jslrt.24021. Epub 2024 Jul 31.
J Clin Exp Hematop. 2024.
PMID: 39085129
Free PMC article.